entity

CD3

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CD3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
11Hypotheses
1Analyses
1Outgoing
0Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (18)

Knowledge base pages for this entity

CD33 — Cluster of Differentiation 33

gene · 2879 words

Neuroimmune Genes in Alzheimer's Disease — TREM2, CD33, PLD3

mechanism · 2162 words

SIGLEC3 Gene (CD33)

gene · 1592 words

CD33 Protein — Cluster of Differentiation 33 (Siglec-3)

protein · 1545 words

CD39 (ENTPD1) Activators for Neurodegeneration

therapeutic · 1308 words

Outgoing (1)

TargetRelationTypeStr
IL30associated_withgene0.80

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (11)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
CD38 Inhibition for NAD+ Restoration and Microglial Senescen 0.575 neurodegeneration Microglial subtypes in neurodegeneration
Circulating Endothelial Microparticles Expressing Activated 0.565 - What blood-brain barrier permeability ch
CD300f Immune Checkpoint Activation 0.545 neurodegeneration Gene expression changes in aging mouse b
CD36 Acts as Primary Aβ Oligomer Sensor on Perivascular Macr 0.535 neurodegeneration How do perivascular cells specifically r
CD33-Dependent Switch Hypothesis: CD33 Antagonism Redirects 0.519 synaptic-biology Does SPP1-mediated synaptic engulfment r
Astrocyte CD38-erk Mapk signaling controls mitochondrial tra 0.380 als-and-alzheimers Mitochondrial transfer between neurons a
CD38 Inhibition to Preserve NAD+ Pools and Prevent PARP1-Med 0.380 metabolomics Metabolomic signatures of neurodegenerat
CD38 Inhibition to Prevent NAD+ Depletion and Restore Cellul 0.380 metabolomics Metabolomic signatures of neurodegenerat
CD300f Immunoglobulin Receptor as Neuroinflammatory Brake 0.105 neurodegeneration Neuroinflammation Biomarker Panel for Ea
CD38 Agonist Therapy for Alzheimer's Disease 0.000 - Mitochondrial transfer between astrocyte
CD33-Sialic Acid Pathway Modulation in Microglia 0.000 - Cell type vulnerability in Alzheimer's D

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.586

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (3)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Microglia at the Forefront: New Insights From the Glial Club South Cone Meeting [PMID:41668347] Giambartolomei GH, Iribarren P, Pasquini J Neurochem 2026 0
Corrigendum to “CD300f enables microglial damage sensing, efferocytosis, and apo [PMID:41734445] Negro-Demontel Luciana; Evans Frances; C Brain, Behavior, and Immunity 2026 0
IgE-dependent anaphylaxis is regulated by sphingolipid binding to activating and [PMID:41790557] Izawa K, Kaitani A, Enomoto Y, Ando T, Y Cell Rep 2026 0

Debates (1)

Multi-agent debates referencing this entity

The abstract shows TYROBP deficiency is neuroprotective despite being required f

closed · Rounds: 4 · Score: 0.56 · 2026-04-15

Related Research

Hypotheses and analyses mentioning CD3 in their description or question text

Astrocyte CD38-erk Mapk signaling controls mitochondrial transfer to neurons via

Score: 0.380 · als-and-alzheimers · 2026-04-27

Under neurodegenerative stress, astrocytes upregulate CD38, which triggers Erk MAPK signaling to promote tunneling nanot

CD38 Inhibition to Preserve NAD+ Pools and Prevent PARP1-Mediated Metabolic Dysf

Score: 0.380 · metabolomics · 2026-04-27

This hypothesis proposes that CD38, the primary NAD+-consuming enzyme, represents a more effective therapeutic target th

CD38 Inhibition to Prevent NAD+ Depletion and Restore Cellular Bioenergetics in

Score: 0.380 · metabolomics · 2026-04-26

This hypothesis proposes that targeting CD38, the primary NAD+-consuming enzyme, represents a more direct therapeutic ap

CD300f Immunoglobulin Receptor as Neuroinflammatory Brake

Score: 0.105 · neurodegeneration · 2026-04-18

## Mechanistic Overview CD300f Immunoglobulin Receptor as Neuroinflammatory Brake starts from the claim that modulating

CD38 Agonist Therapy for Alzheimer's Disease

Score: 0.000 · unknown disease · 2026-04-28

Pharmacological activation of CD38 in astrocytes could enhance mitochondrial release and transfer to neurons, providing

CD33-Sialic Acid Pathway Modulation in Microglia

Score: 0.000 · unknown disease · 2026-04-28

CD33 is a microglial-specific sialic acid-binding receptor that regulates immune activation. Modulating CD33-mediated si